Myriad Logo
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Prenatal careIs my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is a pregnancy’s risk of genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk™ gene table
      • Provider resources
        • Order a test
        • Documents & forms
        • Scope of service & lab certificates
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk™ (cancer treatment)
        • MyRisk™ (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
  • About Myriad
    • Who we are
      • Our science & innovation
      • Corporate & social responsibility
    • Latest news
      • Myriad Genetics Blog
    • Corporate information
      • Our leadership
      • Patient advocacy partners
      • Investor relations
      • Careers
ORDER
    Order
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Prenatal careIs my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is a pregnancy’s risk of genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk™ gene table
      • Provider resources
        • Order a test
        • Documents & forms
        • Scope of service & lab certificates
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk™ (cancer treatment)
        • MyRisk™ (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
  • About Myriad
    • Who we are
      • Our science & innovation
      • Corporate & social responsibility
    • Latest news
      • Myriad Genetics Blog
    • Corporate information
      • Our leadership
      • Patient advocacy partners
      • Investor relations
      • Careers

Category: News

News
  • Category
    • All
    • clinical
    • Counsyl Complete
    • Counsyl Culture
    • Engineering, Design and Analytics
    • Events
    • Genomics and Genetic Counseling
    • Human Understanding
    • News
    • Patients
    • Product
    • Reproductive Health
    • Stories
    • Uncategorized

Integrating Genetic Testing into a Telehealth Program

June 30, 2020

Introducing Human Understanding a new podcast series from Myriad Women's Health. Each episode highlights real stories of providers in our communities who are m...

Continue Reading

Re-creating Patient /Provider Interaction: Telemedicine, The Next Frontier

May 28, 2020

Introducing Human Understanding a new podcast series from Myriad Women's Health. Each episode highlights real stories of providers in our communities who are m...

Continue Reading

Virtual Risk Assessment and Patient Education Can Help Limit In-Person Exposure

May 14, 2020

In order to adapt to the changing healthcare environment and patients’ needs, Myriad has expanded its patient education services to support patients at home....

Continue Reading

Supporting you and your patients through uncertain times

May 5, 2020

Over the past several weeks, incredible efforts have been made by healthcare professionals all over the world in response to the COVID-19 pandemic.  While...

Continue Reading

Integrating Genetic Testing into a Telehealth Program

April 29, 2020

Dr. Candace Westgate*, an OB/GYN physician in California, explains her recent experience incorporating genetic testing through virtual visits into her practice...

Continue Reading

Providing testing services without interruptions

March 30, 2020

During this unique time our nation is experiencing, Myriad is dedicated to finding solutions to ensure that patient care is not interrupted. Dr. Thomas Slavin,...

Continue Reading

A Message from Myriad about COVID-19

March 17, 2020

In light of the public health preparedness efforts currently underway, Myriad’s top priorities are protecting the health and safety of employees, our customer...

Continue Reading

Prequel Proven Effective – Says Two Peer-Reviewed Publications

February 14, 2020

Two peer-reviewed publications show that the Myriad Women’s Health NIPS solution, Prequel Carrier Screen, is accurate across all types of patients, including...

Continue Reading

Announcement: Counsyl transitioning to Myriad Women’s Health, Inc.

September 10, 2018

Counsyl is proud to announce that our acquisition closed on July 31, 2018 and we have officially combined with Myriad Preventative Care to form Myriad Women’s...

Continue Reading

Better Access to Genetic Screening for Your Patients

July 11, 2018

Counsyl is committed to making genetic screening accessible for your patients through Counsyl Complete™, our comprehensive suite of support services. This ...

Continue Reading

Announcement: Counsyl to be acquired by Myriad

May 29, 2018

Patients, Physicians and Counsyl Employees, The news is now public: Myriad is acquiring Counsyl, with the transaction expected to close at the end of July. We h...

Continue Reading

Announcement: Counsyl and UnitedHealthCare Status

May 24, 2018

Counsyl and UnitedHealthcare (UHC) have not been able to come to terms on the renewal of our network participation agreement and we anticipate that Counsyl will...

Continue Reading

Counsyl celebrates International Women’s Day

March 8, 2018

International Women’s Day celebrates and acknowledges women for their accomplishments and their strength. As a leader in women’s health, Counsyl helps impr...

Continue Reading

Introducing the new counsyl.com

March 2, 2018

We are excited to announce significant updates to our website: counsyl.com. In addition to a fresh look, we’ve made the site easier to navigate and added new ...

Continue Reading

We’ve delivered our one millionth screen

January 30, 2018

​This week we crossed an incredible milestone: we’ve delivered our one millionth screen. We started Counsyl over ten years ago.  At the time, we were tech...

Continue Reading
  • 1
  • 2
  • 3
  • 4
  • Managed care
    • Payers
  • Investors
    • Investor relations
  • News
    • Press releases
    • Myriad Genetics’ Blog
  • About
    • Careers
    • Contact us
  • Terms of Use
  • Myriad Genetics, Inc. Privacy Policy
  • Notice of Privacy Practices
  • Language Assistance
  • Cookie Preferences
facebook linkedin twitter instagram youtube

Health. Illuminated.

  • © 2023 Myriad Genetics, Inc.